Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples